Besides, to investigate clinical features associated with ATM in melanoma patients, we evaluated ATM across different clinical features, showing that patients with Age < 60, Clark levels I–III and IV had lower ATM relative to those with Clark level V (Fig. S5). The gene discussed is ATM; the disease is melanoma.